237 related articles for article (PubMed ID: 35410851)
21. SARS-CoV-2 infection in patients with autoimmune hepatitis.
Marjot T; Buescher G; Sebode M; Barnes E; Barritt AS; Armstrong MJ; Baldelli L; Kennedy J; Mercer C; Ozga AK; Casar C; Schramm C; ; Moon AM; Webb GJ; Lohse AW
J Hepatol; 2021 Jun; 74(6):1335-1343. PubMed ID: 33508378
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune hepatitis or drug-induced autoimmune hepatitis following Covid-19 vaccination?
Fimiano F; D'Amato D; Gambella A; Marzano A; Saracco GM; Morgando A
Liver Int; 2022 May; 42(5):1204-1205. PubMed ID: 35230737
[No Abstract] [Full Text] [Related]
23. SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis.
Schneider L; Schubert L; Winkler F; Munda P; Winkler S; Tobudic S
Clin Gastroenterol Hepatol; 2022 Sep; 20(9):2145-2147.e2. PubMed ID: 35487452
[TBL] [Abstract][Full Text] [Related]
24. Severe Hepatitis-associated Aplastic Anemia Following COVID-19 mRNA Vaccination.
Yamamoto M; Keino D; Sumii S; Yokosuka T; Goto H; Inui A; Sogo T; Kawakami M; Tanaka M; Yanagimachi M
Intern Med; 2023 Jun; 62(12):1813-1816. PubMed ID: 36948624
[TBL] [Abstract][Full Text] [Related]
25. Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence?
Trontzas IP; Kyriakoulis KG; Vathiotis IA; Syrigos A; Kounadis G; Siasiakou S; Poulakou G
Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560483
[TBL] [Abstract][Full Text] [Related]
26. Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation.
Alqahtani SA; Barry M; Memish Z; Hashim A; Alfares MA; Alghamdi SA; Al-Hamoudi WK; Al-Judaibi B; Alhazzani W; Al-Tawfiq JA; Abaalkhail F
Saudi J Gastroenterol; 2021; 27(4):201-207. PubMed ID: 34100388
[TBL] [Abstract][Full Text] [Related]
27. Auto-immune hepatitis following COVID vaccination.
Rela M; Jothimani D; Vij M; Rajakumar A; Rammohan A
J Autoimmun; 2021 Sep; 123():102688. PubMed ID: 34225251
[TBL] [Abstract][Full Text] [Related]
28. Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review.
Ueno M; Takabatake H; Itakura J; Fujita R; Kayahara T; Morimoto Y; Notohara K; Mizuno M
Clin J Gastroenterol; 2023 Aug; 16(4):554-558. PubMed ID: 37029249
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort.
Geisen UM; Berner DK; Tran F; Sümbül M; Vullriede L; Ciripoi M; Reid HM; Schaffarzyk A; Longardt AC; Franzenburg J; Hoff P; Schirmer JH; Zeuner R; Friedrichs A; Steinbach A; Knies C; Markewitz RD; Morrison PJ; Gerdes S; Schreiber S; Hoyer BF
Ann Rheum Dis; 2021 Oct; 80(10):1306-1311. PubMed ID: 33762264
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 Vaccination in Patients with Chronic Liver Disease.
Schinas G; Polyzou E; Mitropetrou F; Pazionis A; Gogos C; Triantos C; Akinosoglou K
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560782
[TBL] [Abstract][Full Text] [Related]
31. Italian association for the study of the liver position statement on SARS-CoV2 vaccination.
Russo FP; Piano S; Bruno R; Burra P; Puoti M; Masarone M; Montagnese S; Ponziani FR; Petta S; Aghemo A;
Dig Liver Dis; 2021 Jun; 53(6):677-681. PubMed ID: 33941488
[TBL] [Abstract][Full Text] [Related]
32. [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
Costa Frossard-França L; García-Domínguez JM; Moreno-Torres I; Fortún J; Villar LM; Meca-Lallana V
Rev Neurol; 2021 Apr; 72(7):250-260. PubMed ID: 33764494
[TBL] [Abstract][Full Text] [Related]
33. New-onset autoimmune phenomena post-COVID-19 vaccination.
Chen Y; Xu Z; Wang P; Li XM; Shuai ZW; Ye DQ; Pan HF
Immunology; 2022 Apr; 165(4):386-401. PubMed ID: 34957554
[TBL] [Abstract][Full Text] [Related]
34. Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report.
Lasagna A; Lenti MV; Cassaniti I; Sacchi P
Immunotherapy; 2022 Aug; 14(12):915-925. PubMed ID: 35694999
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease.
Luxenburger H; Thimme R
Gut; 2023 Sep; 72(9):1783-1794. PubMed ID: 37316169
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later.
Ekpanyapong S; Bunchorntavakul C; Reddy KR
J Viral Hepat; 2022 Jan; 29(1):4-20. PubMed ID: 34352133
[TBL] [Abstract][Full Text] [Related]
37. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.
Fix OK; Blumberg EA; Chang KM; Chu J; Chung RT; Goacher EK; Hameed B; Kaul DR; Kulik LM; Kwok RM; McGuire BM; Mulligan DC; Price JC; Reau NS; Reddy KR; Reynolds A; Rosen HR; Russo MW; Schilsky ML; Verna EC; Ward JW; Fontana RJ;
Hepatology; 2021 Aug; 74(2):1049-1064. PubMed ID: 33577086
[TBL] [Abstract][Full Text] [Related]
38. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
Schulze-Koops H; Specker C; Skapenko A
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
[TBL] [Abstract][Full Text] [Related]
39. Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients.
Sansone G; Bonifati DM
J Neurol; 2022 Aug; 269(8):3965-3981. PubMed ID: 35503373
[TBL] [Abstract][Full Text] [Related]
40. The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.
Correia AL; Leal R; Pimenta AC; Fernandes M; Guedes Marques M; Rodrigues L; Santos L; Romãozinho C; Sá H; Pratas J; Araújo L; Figueiredo A; Alves R
Clin Transplant; 2022 Apr; 36(4):e14585. PubMed ID: 34997797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
